Abstract
G-protein-coupled receptors (GPCRs) are essential components of the signalling network throughout the body. To understand the molecular mechanism of G-protein-mediated signalling, solved structures of receptors in inactive conformations and in the active conformation coupled to a G protein are necessary. Here we present the structure of the adenosine A(2A) receptor (A(2A)R) bound to an engineered G protein, mini-Gs, at 3.4 Å resolution. Mini-Gs binds to A(2A)R through an extensive interface (1,048 Å2) that is similar, but not identical, to the interface between Gs and the β2-adrenergic receptor. The transition of the receptor from an agonist-bound active-intermediate state to an active G-protein-bound state is characterized by a 14 Å shift of the cytoplasmic end of transmembrane helix 6 (H6) away from the receptor core, slight changes in the positions of the cytoplasmic ends of H5 and H7 and rotamer changes of the amino acid side chains Arg3.50, Tyr5.58 and Tyr7.53. There are no substantial differences in the extracellular half of the receptor around the ligand binding pocket. The A(2A)R-mini-Gs structure highlights both the diversity and similarity in G-protein coupling to GPCRs and hints at the potential complexity of the molecular basis for G-protein specificity.
MeSH Terms
Adenosine A2 Receptor Agonists/metabolism
Amino Acid Sequence
Binding Sites
Crystallization
Crystallography, X-Ray
Cytoplasm/metabolism
Heterotrimeric GTP-Binding Proteins/chemistry,metabolism
Humans
Ligands
Models, Molecular
Molecular Sequence Data
Protein Conformation
Receptor, Adenosine A2A/chemistry,metabolism
Receptors, Adrenergic, beta-2/chemistry,metabolism
Substrate Specificity
Chemicals
Adenosine A2 Receptor Agonists
Ligands
Receptor, Adenosine A2A
Receptors, Adrenergic, beta-2
Heterotrimeric GTP-Binding Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Carpenter Byron
Nehmé Rony
Warne Tony
Leslie Andrew G W
Tate Christopher G
References (31)
31 references, click to expand
-
Human A(2A) adenosine receptors: high-affinity agonist binding to receptor-G protein complexes containing Gbeta(4).
Mol Pharmacol. 2002 Feb;61(2):455-62
PMID: 11809871
-
Developments in the CCP4 molecular-graphics project.
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2288-94
PMID: 15572783
-
The integration of macromolecular diffraction data.
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):48-57
PMID: 16369093
-
Scaling and assessment of data quality.
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82
PMID: 16369096
-
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
Science. 2008 Nov 21;322(5905):1211-7
PMID: 18832607
-
Phaser crystallographic software.
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
PMID: 19461840
-
Features and development of Coot.
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
PMID: 20383002
-
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.
Nature. 2011 Jan 13;469(7329):175-80
PMID: 21228869
-
Structure and function of an irreversible agonist-β(2) adrenoceptor complex.
Nature. 2011 Jan 13;469(7329):236-40
PMID: 21228876
-
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.
Nature. 2011 Jan 13;469(7329):241-4
PMID: 21228877
-
Structure of an agonist-bound human A2A adenosine receptor.
Science. 2011 Apr 15;332(6027):322-7
PMID: 21393508
-
Structural insights into adrenergic receptor function and pharmacology.
Trends Pharmacol Sci. 2011 Apr;32(4):213-8
PMID: 21414670
-
Overview of the CCP4 suite and current developments.
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
PMID: 21460441
-
REFMAC5 for the refinement of macromolecular crystal structures.
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
PMID: 21460454
-
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
Nature. 2011 May 18;474(7352):521-5
PMID: 21593763
-
Crystal structure of the β2 adrenergic receptor-Gs protein complex.
Nature. 2011 Jul 19;477(7366):549-55
PMID: 21772288
-
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.
Structure. 2011 Sep 7;19(9):1283-93
PMID: 21885291
-
Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.
J Med Chem. 2012 Mar 8;55(5):1898-903
PMID: 22220592
-
G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody.
Nature. 2012 Jan 29;482(7384):237-40
PMID: 22286059
-
Agonist-bound structures of G protein-coupled receptors.
Curr Opin Struct Biol. 2012 Aug;22(4):482-90
PMID: 22480933
-
Structural basis for allosteric regulation of GPCRs by sodium ions.
Science. 2012 Jul 13;337(6091):232-6
PMID: 22798613
-
High-resolution crystal structure of human protease-activated receptor 1.
Nature. 2012 Dec 20;492(7429):387-92
PMID: 23222541
-
Molecular signatures of G-protein-coupled receptors.
Nature. 2013 Feb 14;494(7436):185-94
PMID: 23407534
-
Molecular control of δ-opioid receptor signalling.
Nature. 2014 Feb 13;506(7487):191-6
PMID: 24413399
-
The 2.1 Å resolution structure of cyanopindolol-bound β1-adrenoceptor identifies an intramembrane Na+ ion that stabilises the ligand-free receptor.
PLoS One. 2014 Mar 24;9(3):e92727
PMID: 24663151
-
Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor.
Mol Pharmacol. 2015 Jun;87(6):907-15
PMID: 25762024
-
Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling.
Cell. 2015 May 21;161(5):1101-1111
PMID: 25981665
-
Universal allosteric mechanism for Gα activation by GPCRs.
Nature. 2015 Aug 13;524(7564):173-179
PMID: 26147082
-
Structural insights into µ-opioid receptor activation.
Nature. 2015 Aug 20;524(7565):315-21
PMID: 26245379
-
Activation of the A2A adenosine G-protein-coupled receptor by conformational selection.
Nature. 2016 May 04;533(7602):265-8
PMID: 27144352
-
Engineering a minimal G protein to facilitate crystallisation of G protein-coupled receptors in their active conformation.
Protein Eng Des Sel. 2016 Dec;29(12):583-594
PMID: 27672048